Orient Pharma recalls Pitavastatin 1mg tablets (Rx only) due to failed impurities and degradation. Affected lots expire through 2027. Consumers should contact Teva Pharmaceuticals for details.
Failed Impurities/Degradation Specifications.
Orient Pharma is recalling Pitavastatin 1mg tablets (Rx only) because they may contain impurities or degrade. This could affect safety for people using these prescription medications.
The tablets may have failed impurities or degradation specifications, which could pose a safety risk. This is a drug recall due to potential quality issues that might affect the medication's safety.
People with a prescription for Pitavastatin 1mg tablets from the recalled lots. Those using the medication as directed are most at risk.
Check the product label for the lot numbers P051001 through P051015, which were manufactured by Orient Pharma Co., Ltd. in Yunlin, Taiwan. The expiration dates range from July 2025 to January 2027.
Look for lot numbers P051001 through P051015 on the tablet packaging.
The tablets may contain impurities or degrade, which could affect safety. This is a drug recall due to failed impurities and degradation specifications.
Check the product label for lot numbers P051001 through P051015, which were manufactured by Orient Pharma Co., Ltd. in Yunlin, Taiwan.
The recall record does not specify a remedy. Contact Teva Pharmaceuticals for further instructions.
We’ve drafted a message you can send Orient Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0527-2025 — Orient Pharma Orient Pharma Hello, I own a Orient Pharma that is covered by recall D-0527-2025 from Orient Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
